SK286589B6 - Substancie na použitie v liečbe psoriázy - Google Patents

Substancie na použitie v liečbe psoriázy Download PDF

Info

Publication number
SK286589B6
SK286589B6 SK991-2002A SK9912002A SK286589B6 SK 286589 B6 SK286589 B6 SK 286589B6 SK 9912002 A SK9912002 A SK 9912002A SK 286589 B6 SK286589 B6 SK 286589B6
Authority
SK
Slovakia
Prior art keywords
psoriasis
diacerein
treatment
arthritis
ritchie
Prior art date
Application number
SK991-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK9912002A3 (en
Inventor
Napoli Guido Di
Original Assignee
Laboratoire Medidom S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom S. A. filed Critical Laboratoire Medidom S. A.
Publication of SK9912002A3 publication Critical patent/SK9912002A3/sk
Publication of SK286589B6 publication Critical patent/SK286589B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK991-2002A 2000-01-12 2001-01-08 Substancie na použitie v liečbe psoriázy SK286589B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (2)

Publication Number Publication Date
SK9912002A3 SK9912002A3 (en) 2003-02-04
SK286589B6 true SK286589B6 (sk) 2009-01-07

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
SK991-2002A SK286589B6 (sk) 2000-01-12 2001-01-08 Substancie na použitie v liečbe psoriázy

Country Status (22)

Country Link
US (2) US6844365B2 (da)
EP (1) EP1248608B1 (da)
JP (1) JP4912554B2 (da)
CN (1) CN1187045C (da)
AR (1) AR026801A1 (da)
AT (1) ATE254913T1 (da)
AU (1) AU776324B2 (da)
BR (2) BR0107493A (da)
CA (1) CA2396111C (da)
CZ (1) CZ301129B6 (da)
DE (1) DE60101309T2 (da)
DK (1) DK1248608T3 (da)
ES (1) ES2210120T3 (da)
IL (2) IL150390A0 (da)
MX (1) MXPA02006610A (da)
PL (1) PL212010B1 (da)
PT (1) PT1248608E (da)
RU (1) RU2266740C2 (da)
SK (1) SK286589B6 (da)
TR (1) TR200400228T4 (da)
WO (1) WO2001051044A2 (da)
ZA (1) ZA200205148B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
TWI399384B (zh) 2005-05-16 2013-06-21 Abbott Biotech Ltd ＴＮＦα抑制劑於治療侵蝕型多發性關節炎之用途
US9624295B2 (en) * 2006-04-10 2017-04-18 Abbvie Biotechnology Ltd. Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
KR101567925B1 (ko) * 2010-04-08 2015-11-10 티더블유아이 바이오테크놀로지 인코포레이티드 당뇨병 보조치료요법으로서 디아세레인을 사용하는 방법
US20180311199A1 (en) * 2016-01-12 2018-11-01 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
US10675260B2 (en) 2017-01-19 2020-06-09 Twi Biotechnology, Inc. Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
CA3094295A1 (en) * 2018-03-29 2019-10-03 S.I.S. Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
IL150390A (en) 2007-07-24
JP4912554B2 (ja) 2012-04-11
WO2001051044A2 (en) 2001-07-19
AU2213201A (en) 2001-07-24
PL212010B1 (pl) 2012-07-31
BRPI0107493B1 (pt) 2019-04-16
CN1187045C (zh) 2005-02-02
ATE254913T1 (de) 2003-12-15
IL150390A0 (en) 2002-12-01
DK1248608T3 (da) 2004-04-05
TR200400228T4 (tr) 2004-02-23
CZ20022382A3 (cs) 2002-11-13
WO2001051044A3 (en) 2002-03-28
RU2266740C2 (ru) 2005-12-27
US20020143057A1 (en) 2002-10-03
PL356784A1 (en) 2004-07-12
CA2396111C (en) 2008-12-02
US6844365B2 (en) 2005-01-18
EP1248608A2 (en) 2002-10-16
US20050004045A1 (en) 2005-01-06
CN1395484A (zh) 2003-02-05
DE60101309T2 (de) 2004-09-16
MXPA02006610A (es) 2004-09-10
BR0107493A (pt) 2002-10-08
ES2210120T3 (es) 2004-07-01
EP1248608B1 (en) 2003-11-26
AR026801A1 (es) 2003-02-26
PT1248608E (pt) 2004-04-30
DE60101309D1 (de) 2004-01-08
BRPI0107493B8 (pt) 2021-05-25
JP2003519653A (ja) 2003-06-24
SK9912002A3 (en) 2003-02-04
CZ301129B6 (cs) 2009-11-11
ZA200205148B (en) 2003-06-26
AU776324B2 (en) 2004-09-02
CA2396111A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
SK286589B6 (sk) Substancie na použitie v liečbe psoriázy
Cheng et al. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis
CN109908140A (zh) 生物素治疗多发性硬化的用途
IL133976A (en) Agents for the treatment of skin disorders
Lewis et al. Dose effects of chlorpromazine on human sleep
EP0502048A1 (en) USE OF CAFFEINE IN THE TREATMENT OF INFECTIONS RELATING TO HERPES "BUTTON OF FEVER".
Rossi et al. A double-blind comparison between diclofenac sodium and ibuprofen in osteoarthritis
JP2000336034A (ja) ケモカイン産生促進剤
CN109381465A (zh) 沃诺拉赞在制备抗痛风制剂中的应用
US11564901B2 (en) Compositions and methods of use of phorbol esters
CN111000983A (zh) 一种新的重组人白细胞介素-1受体拮抗剂的药用用途
TW202116297A (zh) 組合療法之方法、組成物與套組
Sperryn et al. Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis.
Lam et al. Reducing meal-stimulated acid secretion versus reducing nocturnal acid secretion for healing of duodenal ulcer
Dihydrochloride AHFS® firstRelease™
Hullin Absorption of lithium from controlled-release preparations.
Barde Psoriasis and lichen planus
TW202245783A (zh) 一種吡咯并嘧啶類化合物的應用
CN117860765A (zh) 麦角甾醇在制备治疗和/或预防银屑病药物中的应用
Cream ALDARA®(imiquimod) Cream, 5%
CN118059095A (zh) 一种香草木宁碱在制备治疗类风湿性关节炎的药物中的应用
WO2023204754A1 (en) Treatment of autoimmune skin disease
EP3980021A1 (en) Methods of treating and/or preventing psoriasis
Tablets et al. Pr TEVA-TERAZOSIN
Swinson Polymyalgia arteritica

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20210108